[(η5-(2-NMe2-3-P(S)(i-Pr)2-indene))Mn(CO)3] | 808760-37-4

• 英文名称: [(η5-(2-NMe2-3-P(S)(i-Pr)2-indene))Mn(CO)3]
• 英文别名: (η5-1-P(S)(i-Pr)2-2-NMe2-indenyl)Mn(CO)3；Mn(I)(η5-1-PS(iPr)2-2-NMe2-indenyl)(CO)3
• CAS: 808760-37-4
• 化学式: C₂₀H₂₅MnNO₃PS
• 分子量: 445.401
• InChiKey: BRLNAWFLUCIZDD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  None
• 重原子数：
  None
• 可旋转键数：
  None
• 环数：
  None
• sp3杂化的碳原子比例：
  None
• 拓扑面积：
  None
• 氢给体数：
  None
• 氢受体数：
  None

反应信息

• 作为反应物：
  描述：

  [(η5-(2-NMe2-3-P(S)(i-Pr)2-indene))Mn(CO)3] 在 hexachlorodisilane 作用下， 以 甲苯 为溶剂， 以56%的产率得到[(η5-(2-NMe2-3-P(i-Pr)2-indene))Mn(CO)3]
  参考文献：
  名称：

  供体官能化茚的新型锰（I）配合物的合成及晶体学表征

  摘要：

  1-P i的治疗PR 2 -2-NME 2 -茚（2 [H]）与BrMn（CO）5 κ提供2 - P，ñ - （2-NME 2 -3-P我Pr 2-茚）Mn（CO）3 Br（4）的产率为73％。将AgBF 4或AgSO 3 CF 3加到4分别得到相应的内球四氟硼酸酯（5a）和三氟甲磺酸酯（5b）配合物，产率分别为62％和65％。去质子化4，图5a，或5b中产生的产品的一个棘手的混合物。阳离子络合物[κ 2 - P，ñ - （2-NME 2 -3-P我PR 2 -茚）的Mn（CO）4 ] + BF 4 - （6）通过处理BrMn（CO）在30％的产率制备5用的AgBF 4，然后通过加入2 [H]。η的benzocymantrene 5 - [ 2 ]的Mn（CO）3经还原的56％产率制备η 5 - （2-NME 2 -3-P（S）我Pr 2-茚基）Mn（CO）3与Cl 3 SiSiCl 3。化合物2

  DOI：

  10.1021/om0490435
• 作为产物：
  描述：

  五羰基溴化锰(I) 、 1-P(S)(i-Pr)2-2-NMe2-indene 在 n-butyllithium 作用下， 以 not given 为溶剂， 以96%的产率得到[(η5-(2-NMe2-3-P(S)(i-Pr)2-indene))Mn(CO)3]
  参考文献：
  名称：

  Structurally diverse Rh(i) and Mn(i) complexes derived from the new ambidentate indene ligand, (1-{iPr2P(S)}-2-{NMe2})C9H6

  摘要：

  我们开发出了一种新的茚基配体，其特点是具有悬垂的硫化膦和胺供体片段；Rh(I) 以 κ2-[N,S] 方式与配体的中性形式配位，而配体的阴离子形式则分别以 κ2-[C,S] 和 η5 模式与 Rh(I) 和 Mn(I) 结合。

  DOI：

  10.1039/b410328a

文献信息

• New Racemic Planar-Chiral Metalloligands Derived from Donor-Substituted Indenes:  A Synthetic, Structural, and Catalytic Investigation
  作者：Dominik Wechsler、Matthew A. Rankin、Robert McDonald、Michael J. Ferguson、Gabriele Schatte、Mark Stradiotto

  DOI：10.1021/om700832f

  日期：2007.12.1

  The synthesis and characterization of a new family of (eta(5)-indenyl)MLn complexes (MLn = Mn(CO)(3), Cp*Ru, or Cp*Fe; Cp* = eta(5)-C5Me5) derived from 3-(PPr2)-Pr-i-indene, 1-(PPr2)-Pr-i-2-NMe2-indene (1a[H]), or 1-P(S)Pr-i(2)-2-NMe2-indene (1b[H]) are described. Lithiation of 1b[H] followed by treatment with BrMn(CO)(5), 0.25 equiv of [Cp*RuCl](4), or Cp*Li/FeCl2 provided the corresponding (eta(5)-1b)MLn complexes (MLn = Mn(CO)(3), 2a, 96%; Cp*Ru, 2b, 87%; or Cp*Fe, 2c, 55%). Similarly, treatment of 1a[Li] with 0.25 equiv of [Cp*RuCl](4) or Cp*Li/FeCl2 provided the corresponding (eta(5)-1a)MLn complexes (MLn = Cp*Ru, 3b, 74%; or Cp*Fe, 3c, 62%). Whereas combination of 3b and 0.5 equiv of [(COD)RhCl](2) afforded [(COD)Rh(kappa(2) -P,N-3b)]Cl-+(-) ([4b]Cl-+(-); 49% isolated yield), under similar conditions 3c was observed to undergo a decomposition reaction resulting in the formation of the zwitterionic complex (COD)Rh(kappa(2) -P,N-1a) (5; COD = eta(4)- 1, 5-cyclooctadiene). Each of 3a-c was observed to react cleanly with [(COD)Rh(THF)(2)]+BF4- (prepared in situ) to give the corresponding [(COD)Rh(kappa(2)-P,N-3a-c)]+BF4- complex ([4a-c]+BF4-; 87%, 96%, and 89% isolated yield, respectively). Whereas lithiation of 3-(PPr2)-Pr-i-indene followed by the addition of BrMn(CO)5 generated a complex mixture of products, similar reactions employing 0.25 equiv of [Cp*RuCl](4) Or Cp*Li/FeCl2 afforded 6b or 6c in 98% and 43% yield, respectively. Treatment of 6b with 0.5 equiv of [(COD)RhCl](2) allowed for the isolation of (COD)RhCl(kappa(1)-P-6b) 7 in 96% isolated yield. Each of [4a-c]+BF4- proved to be an active catalyst for addition of pinacolborane to styrene, with the observed regioselectivity being dependent on the nature of the eta(5)-coordinated metal fragment, as well as the solvent employed. Single-crystal X-ray diffraction data for 2a, 2b, 2c, 3b, [4c]+BF4-, and 7 are provided.